Evidence map›Paper›PMID 23171211›Full record

Trial reportOphthalmic epidemiology2012

Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial.

Craig W See, Muthiah Srinivasan, Somu Saravanan, Catherine E Oldenburg, Elizabeth J Esterberg, Kathryn J Ray, Tanya S Glaser, Elmer Y Tu, Michael E Zegans, Stephen D McLeod and 2 more

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Ophthalmic epidemiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Topical corticosteroids as adjunctive therapy for bacterial keratitis.The Cochrane database of systematic reviews · 2014
    Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Higher PEEP for acute respiratory distress syndrome: a Bayesian meta-analysis of randomised clinical trials.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2021
    Article
  6. Prior Elicitation for Use in Clinical Trial Design and Analysis: A Literature Review.International journal of environmental research and public health · 2021
    Review
  7. Role of steroids in the treatment of bacterial keratitis.Clinical ophthalmology (Auckland, N.Z.) · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Craig W SeeFI Proctor Foundation, University of California, San Francisco, CA 94143-0412, USA.
Muthiah Srinivasan
Somu Saravanan
Catherine E Oldenburg
Elizabeth J Esterberg
Kathryn J Ray
Tanya S Glaser
Elmer Y Tu
Michael E Zegans
Stephen D McLeod
Nisha R Acharya
Thomas M Lietman
University of California, San Francisco · USSan Francisco Foundation · USAravind Eye Hospital · INDartmouth College · USUniversity of Illinois Chicago · US

Funding

Rapid-Prototyping and Design CoreP30EY002162 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ULLIAN, ERIK M · 1985 to 2024
$16.8M
The Steroids for Cornea Ulcers TrialU10EY015114 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LIETMAN, THOMAS M · 2005 to 2009
$2.4M
Predicting and Improving Clinical Outcomes for Bacterial KeratitisK23EY017897 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ACHARYA, NISHA · 2007 to 2011
$1.1M
NEI NIH HHS EY02162NEI NIH HHS K23 EY017897NEI NIH HHS P30 EY002162NEI NIH HHS U10 EY015114
6 · The paper itself

Abstract

purposeTo elicit expert opinion on the use of adjunctive corticosteroid therapy in bacterial corneal ulcers. To perform a Bayesian analysis of the Steroids for Corneal Ulcers Trial (SCUT), using expert opinion as a prior probability.

methodsThe SCUT was a placebo-controlled trial assessing visual outcomes in patients receiving topical corticosteroids or placebo as adjunctive therapy for bacterial keratitis. Questionnaires were conducted at scientific meetings in India and North America to gauge expert consensus on the perceived benefit of corticosteroids as adjunct treatment. Bayesian analysis, using the questionnaire data as a prior probability and the primary outcome of SCUT as a likelihood, was performed. For comparison, an additional Bayesian analysis was performed using the results of the SCUT pilot study as a prior distribution.

resultsIndian respondents believed there to be a 1.21 Snellen line improvement, and North American respondents believed there to be a 1.24 line improvement with corticosteroid therapy. The SCUT primary outcome found a non-significant 0.09 Snellen line benefit with corticosteroid treatment. The results of the Bayesian analysis estimated a slightly greater benefit than did the SCUT primary analysis (0.19 lines verses 0.09 lines).

conclusionIndian and North American experts had similar expectations on the effectiveness of corticosteroids in bacterial corneal ulcers; that corticosteroids would markedly improve visual outcomes. Bayesian analysis produced results very similar to those produced by the SCUT primary analysis. The similarity in result is likely due to the large sample size of SCUT and helps validate the results of SCUT.

Indexed as

Administration, TopicalAnti-Infective AgentsAza CompoundsBayes TheoremCorneal UlcerDouble-Blind MethodEye Infections, BacterialFluoroquinolonesGlucocorticoidsHumansMoxifloxacinOphthalmic SolutionsPrednisoloneQuinolinesSurveys and QuestionnairesTreatment OutcomeAnti-Infective AgentsAza CompoundsFluoroquinolonesGlucocorticoidsMoxifloxacinOphthalmic SolutionsPrednisoloneprednisolone phosphateQuinolines

Identifiers

PMID23171211
PMCPMC3830548
OpenAlexW2024218828

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.